These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19748393)

  • 1. Aspirin in the primary prevention of vascular disease.
    Cornell J
    Lancet; 2009 Sep; 374(9693):878-9; author reply 879. PubMed ID: 19748393
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in the primary prevention of vascular disease.
    Cleland JG
    Lancet; 2009 Sep; 374(9693):878; author reply 879. PubMed ID: 19748392
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin in the primary prevention of vascular disease.
    Jankowski J; Attwood S; deCaestecker J; Barr H
    Lancet; 2009 Sep; 374(9693):877-8; author reply 879. PubMed ID: 19748390
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin in the primary prevention of vascular disease.
    Ambrosi P
    Lancet; 2009 Sep; 374(9693):877; author reply 879. PubMed ID: 19748391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
    Benhamou Y; Lévesque H
    Rev Med Interne; 2009 Dec; 30(12):1001-3. PubMed ID: 19833416
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for primary prevention of cardiovascular disease (revisited).
    Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin for primary prevention: yes or no?
    Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
    J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for primary prevention of cardiovascular disease?
    Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
    Waltering A; Hemkens L; Florack C
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aspirin and primary prevention of vascular diseases in women].
    Laguta PS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():79-84. PubMed ID: 16447559
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention of coronary artery disease by aspirin.
    Taylor J
    Eur Heart J; 2015 Feb; 36(8):467-8. PubMed ID: 25870873
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioprotective aspirin--update on three previous special alerts.
    Wynn RL
    Gen Dent; 2010; 58(2):87-90. PubMed ID: 20236913
    [No Abstract]   [Full Text] [Related]  

  • 16. [Challenges and perspectives of antiplatelet therapy in the secondary prevention of vascular events].
    Fernández-Concepción O; González-García S
    Rev Neurol; 2010 Jan 1-15; 50(1):59-61. PubMed ID: 20073026
    [No Abstract]   [Full Text] [Related]  

  • 17. New daily aspirin guidelines address age, sex differences.
    Mayo Clin Womens Healthsource; 2009 Sep; 13(9):3. PubMed ID: 19652638
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary vascular prevention: The end of the road for aspirin?
    Ajjan RA
    Diab Vasc Dis Res; 2018 Nov; 15(6):475-476. PubMed ID: 30415566
    [No Abstract]   [Full Text] [Related]  

  • 19. The aspirin controversy in primary prevention.
    Raju NC; Eikelboom JW
    Curr Opin Cardiol; 2012 Sep; 27(5):499-507. PubMed ID: 22874127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aspirin resistance].
    Yilmaz MB; Balbay Y; Korkmaz S
    Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.